ACR 2024

Rheumatoid Arthritis

T2T approach in women with RA associated with increased fertility

Presented By

Prof. Radboud Dolhain, Erasmus University Medical Center, the Netherlands

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 12:06

Positive results for vagus nerve stimulation in RA

Presented By

Dr John Tesser, Arizona Arthritis & Rheumatology Associates, AZ, USA

Trial

Phase 3, RESET-RA

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 12:05

Machine learning to aid evaluation of ANA pattern and titer

Presented By

Dr May Choi, University of Calgary, Canada

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 12:04

Systemic Lupus Erythematosus

ACR presents new 2024 Guideline for lupus nephritis

Presented By

Dr Lisa Sammaritano, Weill Cornell Medicine, NY, USA

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:59

Anifrolumab may delay organ damage in SLE

Presented By

Dr Zahi Touma, University of Toronto, Canada

Trial

LASER

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:58

Dapirolizumab pegol associated with less SLE activity and corticosteroid use

Presented By

Dr Megan Clowse, Duke University, NC, USA

Trial

Phase 3, PHOENYCS GO

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:55

Allogeneic CD19-targeting CAR NK-cell therapy for SLE

Presented By

Dr Max Qian, Rui Therapeutics, China

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:54

Osteoarthritis and Osteoporosis

Psoriatic Arthritis

Post-hoc analysis of 3 large trials maps sex differences in PsA

Presented By

Dr Laura Coates, University of Oxford, UK

Trial

Phase 3, DISCOVER-1, DISCOVER-2, COSMOS

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:36

Global recruitment associated with higher placebo responses in PsA trials

Presented By

Dr Andreas Kerschbaumer, Medical University of Vienna, Austria

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:32

Gout

Vasculitis

Fully tapering glucocorticosteroids may be a viable option for GPA

Presented By

Prof. Peter Merkel, University of Pennsylvania, PA, USA

Trial

Phase 3, TAPIR

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:23

Favourable benefit-risk profile of upadacitinib in giant cell arteritis

Presented By

Prof. Peter Merkel, University of Pennsylvania, PA, USA

Trial

Phase 3, SELECT-GCA

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:22

Mycophenolate mofetil plus methotrexate is effective in Takayasu’s arteritis

Presented By

Dr Xiaochuan Sun, Peking Union Medical College Hospital, China

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:20

Miscellaneous

Emapalumab rapidly controls MAS in patients with Still’s disease

Presented By

Dr Alexei Grom, Cincinnati Children's Hospital, OH, USA

Trial

NI-0501-06, EMERALD

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:17

FcRn blocker nipocalimab improves disease activity in Sjögren’s disease

Presented By

Dr Ghaith Noaiseh, University of Kansas Medical Center, KS, USA

Trial

Phase 2, DAHLIAS

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:15

Inebilizumab associated with reduced flare risk in IgG4-related disease

Presented By

Prof. John Stone, Massachusetts General Hospital, MA, USA

Trial

Phase 3, MITIGATE

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:10

General Rheumatology